BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17240993)

  • 1. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
    Case A; Ni J; Yeh LA; Stein RL
    Anal Biochem; 2005 Mar; 338(2):237-44. PubMed ID: 15745743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
    Feng JF; Readon M; Yadav SP; Im MJ
    Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates.
    Case A; Stein RL
    Biochemistry; 2003 Aug; 42(31):9466-81. PubMed ID: 12899634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging structural understanding of transglutaminase 3.
    Ahvazi B; Boeshans KM; Rastinejad F
    J Struct Biol; 2004 Aug; 147(2):200-7. PubMed ID: 15193648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.
    Monsonego A; Friedmann I; Shani Y; Eisenstein M; Schwartz M
    J Mol Biol; 1998 Oct; 282(4):713-20. PubMed ID: 9743620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding.
    Chica RA; Gagnon P; Keillor JW; Pelletier JN
    Protein Sci; 2004 Apr; 13(4):979-91. PubMed ID: 15010546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
    Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
    Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamoyl inhibitors of tissue transglutaminase.
    Pardin C; Pelletier JN; Lubell WD; Keillor JW
    J Org Chem; 2008 Aug; 73(15):5766-75. PubMed ID: 18582115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
    Hitomi K; Ikura K; Maki M
    Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.
    Pardin C; Roy I; Chica RA; Bonneil E; Thibault P; Lubell WD; Pelletier JN; Keillor JW
    Biochemistry; 2009 Apr; 48(15):3346-53. PubMed ID: 19271761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
    Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
    Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme.
    Upchurch HF; Conway E; Patterson MK; Maxwell MD
    J Cell Physiol; 1991 Dec; 149(3):375-82. PubMed ID: 1683874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage.
    Summey BT; Graff RD; Lai TS; Greenberg CS; Lee GM
    J Orthop Res; 2002 Jan; 20(1):76-82. PubMed ID: 11853093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
    Kim SY; Park WM; Jung SW; Lee J
    Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
    Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
    Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
    Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New target against inflammatory diseases: transglutaminase 2.
    Kim SY
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):332-7. PubMed ID: 15507874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of purified rat testicular transglutaminase and age-dependent changes of the enzyme activities.
    Wu YW; Lai WF; Tsai YH
    Int J Biochem Cell Biol; 2005 Feb; 37(2):386-96. PubMed ID: 15474983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transglutaminase activity by GTP in digitonin permeabilized Yoshida tumor cells.
    Bergamini CM; Signorini M; Caselli L; Melandri P
    Biochem Mol Biol Int; 1993 Jul; 30(4):727-32. PubMed ID: 8104619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.